Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...
If you are wondering whether Amgen's current share price still offers value after a strong run, this article walks through ...
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for ...
StockStory.org on MSN
Amgen (AMGN): Buy, sell, or hold post Q3 earnings?
Amgen’s 17.6% return over the past six months has outpaced the S&P 500 by 6.3%, and its stock price has climbed to $328.43 per share. This was partly due to its solid quarterly results, and the ...
Amgen says its MariTide obesity drug helped patients maintain weight loss for a second year, with good safety and fewer side ...
If you want to know who really controls Amgen Inc. (NASDAQ:AMGN), then you'll have to look at the makeup of its share ...
Amgen’s AMGN stock has risen almost 16% in a month. A lot of this price increase is due to strong third-quarter 2025 results, wherein both the top and bottom lines exceeded expectations. Amgen also ...
Key Insights Using the 2 Stage Free Cash Flow to Equity, Amgen fair value estimate is US$637 Current share price ...
Amgen's weight management candidate looks very promising. The large biotech boasts a deep pipeline beyond that segment. Amgen's dividend looks great, and the stock is reasonably valued. Even so, there ...
Major market indexes such as the S&P 500 declined in the first few months of the year, but have since rebounded significantly. In contrast, biotech giant Amgen (NASDAQ: AMGN) started the year strong, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback